BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Policy

  Bristol-Myers Squibb Company Bribed Doctors, California Commissioner Says

  March 18, 2011

   · 

  1 min read
• Deals

  Pfizer Inc. Reviewing Possible Divestitures, Executives Says; R&D Chief Aims to Complete Review This Year

  March 18, 2011

   · 

  1 min read
• Policy

  European Regulators Slap Amgen with Negative Opinion; To Review CHMP Opinion On Vectibix Use With Chemotherapy

  March 18, 2011

   · 

  12 min read
• Policy

  UCB, Inc.'s Xyrem Rejected in EU for Fibromyalgia

  March 18, 2011

   · 

  1 min read
• Drug Development

  GlaxoSmithKline’s Avandia Linked with Heart Risk Again

  March 18, 2011

   · 

  1 min read
• BioForest

  SemBioSys Genetics Inc. Closes $4,000,000 Financing

  March 18, 2011

   · 

  7 min read
• Mylan Pharmaceuticals, Inc. Recalls Two Drugs Due to Dangerous Label Mix-up

  March 18, 2011

   · 

  1 min read
• Policy

  FDA Panel Backs NovoCure Ltd. Experimental Brain-Cancer-Treatment Device

  March 18, 2011

   · 

  3 min read
• BioCapital

  Oxford Finance Corporation and GE Capital Provide $20 Million Senior Credit Facility to NeoVista, Inc.

  March 18, 2011

   · 

  2 min read
• BioMidwest

  Veran Medical Technologies Completes Financing Worth More Than $15 Million

  March 18, 2011

   · 

  1 min read